Rare diseases
Investigational molecules
Locations
Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure
HungaryStudy of RVT-3101 for Treating Moderate to Severe Crohn's Disease in Patients
HungaryStudy on the Safety and Effects of Favezelimab and Pembrolizumab for Patients with Blood Cancers
HungaryStudy on the Effectiveness and Safety of LYR-210 and Dexamethasone for Treating Chronic Sinusitis in Adults Without Nasal Polyps
HungaryStudy on Nipocalimab and Certolizumab for Patients with Active Rheumatoid Arthritis After Advanced Therapy
HungaryStudy on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease
HungaryStudy Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor
HungaryStudy Comparing MK-7684A and Pembrolizumab for Patients with PD-L1 Positive Metastatic Non-Small Cell Lung Cancer
HungaryStudy on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis
HungaryStudy on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
HungaryStudy on Venetoclax, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
HungaryStudy on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments
HungaryTell us about your condition – we search every trial in Europe and connect you with the right site.
